SP
FCSC

Steelhead Partners’s Fibrocell Science Inc. FCSC Stock Holding History

Steelhead Partners’s Portfolio FCSC Stock Details FCSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-833
Closed -$55K – 85
2013
Q3 		$55K Sell
833
-16,928
-95% -$1.37M 0.01% 80
2013
Q2 		$1.63M Buy
+17,761
New +$1.47M 0.15% 53

Other funds holding FCSC

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BGA
Belmont Global Advisors Dallas, Texas $106M AUM 2.89% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Steelhead Partners's FCSC Position: Q4 2013 in Review

Steelhead Partners sold out of Fibrocell Science Inc. (FCSC) in Q4 2013, closing a stake of 833 shares — an estimated $55K sold.

Steelhead Partners first reported a position in FCSC in Q2 2013 and held it in 2 quarters. The position peaked at $1.63M in Q2 2013. 43 funds tracked by Wall St. Rank hold FCSC as of Q4 2013.

  • Steelhead Partners reported no remaining Fibrocell Science Inc. position as of Q4 2013 after selling out during the quarter.
  • Steelhead Partners sold 833 Fibrocell Science Inc. shares in Q4 2013, an estimated $55K.
  • Steelhead Partners first reported a position in Fibrocell Science Inc. in Q2 2013 and held it in 2 quarters.
  • Steelhead Partners's Fibrocell Science Inc. position peaked at $1.63M in Q2 2013.
  • 43 funds tracked by Wall St. Rank held Fibrocell Science Inc. as of Q4 2013.

Based on Steelhead Partners's 13F filing for Q4 2013, filed 14 Feb 2014.